CD4 and nasal cavity polyp: Methanobrevibacter inhibited CCR2 on CD62L+ myeloid dendritic cells, a protective factor against nasal polyps, or mediated elevated levels of CD3 on CD4 regulatory T cells, which ultimately led to an increased risk of polyps.